Michael Murray

发表

The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells

Fanfan Zhou, M. Rahman, Kirsi Bourget, 2022, Pharmacological Reports.

Preclinical evaluation of ixabepilone in combination with VEGF receptor and PARP inhibitors in taxane-sensitive and taxane-resistant MDA-MB-231 breast cancer cells.

Fanfan Zhou, M. Rahman, Kirsi Bourget, 2022, Journal of pharmaceutical sciences.

The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma

M. Madigan, Xue Zhu, Ke Wang, 2022, Cellular Oncology.

The unfolded protein response and the biology of uveal melanoma.

M. Madigan, Xue Zhu, Ke Wang, 2022, Biochimie.

Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acids.

Hassan Choucair, T. Rawling, M. Rahman, 2023, European journal of pharmacology.

An update on inflammation in uveal melanoma.

Fanfan Zhou, T. Rawling, Michael Murray, 2023, Biochimie.

Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents

Michael Murray, Michael Murray, 2023, Clinical Pharmacokinetics.

The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms

Fanfan Zhou, C. Morisseau, T. Rawling, 2024, Biomedicines.

Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells

Xue Zhu, Ke Wang, Fanfan Zhou, 2023, Journal of Cancer.

Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs)

Fanfan Zhou, Q. Zhou, Xukai Jiang, 2023, Pharmaceutics.